莱美药业最新股东户数环比下降12.56%

Group 1 - The number of shareholders for Laimei Pharmaceutical as of November 20 is 30,614, a decrease of 4,399 from the previous period (November 10), representing a decline of 12.56%. This marks the third consecutive period of decline in shareholder numbers [2] - As of the latest closing price, Laimei Pharmaceutical's stock price is 5.01 yuan, reflecting an increase of 2.04%. Since the concentration of shares began, the stock price has cumulatively risen by 0.80%, with 5 days of increases and 6 days of decreases [2] - The latest margin trading data shows that as of November 24, the total margin balance for the stock is 200 million yuan, with a financing balance of 200 million yuan. During the current concentration period, the financing balance has decreased by 6.0383 million yuan, a decline of 2.93% [2] Group 2 - According to the company's third-quarter report, Laimei Pharmaceutical achieved a total operating revenue of 581 million yuan in the first three quarters, a year-on-year decrease of 4.06%. The net profit for the same period is -45.9172 million yuan, a year-on-year decline of 73.82%, with basic earnings per share at -0.0435 yuan [2]